Venmax Drugs and Pharmaceuticals share news and announcements

BSE: 531015Pharmaceuticals & BiotechnologySmall Cap

₹14.48₹0.51 (3.40%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹14.99.

52-week range of traded prices to 23 Oct 2026

₹12.71Low, 17 Sep 2026₹31.49High, 3 Dec 2025

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹17 Cr4,053rd largest listed
P/E: Earlier quarters restated in the year
P/B: Mergernew accounts awaited
Dividend yield: Nonein the last 12 months
Volume, BSE: 7,037

Venmax Drugs and Pharmaceuticals routine notices

53 filed, newest first. Page 1 of 2.

Oct 2026
- 8 Oct · Routine
  Certificate under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. (opens in a new tab)
Sep 2026
- 25 Sep · Routine
  Intimation of Closure of Trading Window pursuant to declaration of Unaudited Financial Results for the quarter ended September 30, 2026. (opens in a new tab)
- 24 Sep · Routine
  News paper Advertaisement of the meeting of Equity Share Holders Of Venmax Drugs and Pharmaceuticals Limited to be convened as per directions of Hon"ble National Company Law Tribunal .... (opens in a new tab)
Aug 2026
- 8 Aug · Routine
  Newspaper Publication of the Unaudited Financial Results for the Quarter ended June 30, 2026. (opens in a new tab)
Jul 2026
- 14 Jul · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. (opens in a new tab)
Jun 2026
- 27 Jun · Routine
  Intimation of Closure of Trading Window pursuant to declaration of unaudited financial results for the quarter ended June 30, 2026. (opens in a new tab)
May 2026
- 15 May · Routine
  Newspaper Advertisement of the Audited Financial results for the Quarter and Year ended March 31, 2026. (opens in a new tab)
Apr 2026
- 14 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 14 Apr · Routine
  Submission of Annual Secretarial Compliance Report for the year ended March 31, 2026. (opens in a new tab)
- 14 Apr · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. (opens in a new tab)
Mar 2026
- 26 Mar · Routine
  Intimation of Closure of Trading Window pursuant to declaration of Audited Financial Results for the Quarter and Year ended March 31, 2026. (opens in a new tab)
Feb 2026
- 9 Feb · Routine
  Newspaper Publication of unaudited financial results for the quarter and nine months ended December 31, 2025. (opens in a new tab)
Jan 2026
- 12 Jan · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2025. (opens in a new tab)
Dec 2025
- 26 Dec · Routine
  Intimation of Closure of Trading Window for the Quarter ended December 31, 2025. (opens in a new tab)
Nov 2025
- 14 Nov · Routine
  Newspaper Publication of unaudited financials results for the Quarter and Half Year ended September 30, 2025. (opens in a new tab)
Oct 2025
- 14 Oct · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025. (opens in a new tab)
Sep 2025
- 26 Sep · Routine
  Intimation of Closure of Trading Window for the Quarter and Half year ended September 30, 2025. (opens in a new tab)
Aug 2025
- 25 Aug · Routine
  Closure Trading Window for amalgamation of Venmax Drugs and Pharmaceuticals Limited with Hatri Pharma Private Limited. (opens in a new tab)
Jul 2025
- 24 Jul · Routine
  Enclosed herewith copies of the Newspaper publications providing Audited Financial Results for the Quarter ended June 30, 2025 (opens in a new tab)
- 14 Jul · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants Regulations, 2018 for the quarter ended June 30, 2025. (opens in a new tab)
Jun 2025
- 27 Jun · Routine
  Intimation of Closure of Trading Window under Regulation 30 of SEBI LODR Regulations, 2015 for the Quarter ended June 30, 2025. (opens in a new tab)
May 2025
- 10 May · Routine
  Enclosed here with copies of Newspaper publications providing Audited financial results for the Quarter and Year ended March 31st, 2025. (opens in a new tab)
- 5 May · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 5 May · Routine
  Submission of Annual Secretarial Compliance Report for the Year ended 31st March 2025. (opens in a new tab)
Apr 2025
- 9 Apr · Routine
  Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter and Year ended March 31, 2025. (opens in a new tab)
Mar 2025
- 28 Mar · Routine
  Intimation of Closure of Trading Window under Regulation 30 of SEBI LODR Regulations, 2015 for the Quarter and Year ended 31st March 2025. (opens in a new tab)
Feb 2025
- 10 Feb · Routine
  Pursuant to the provisions of the SEBI LODR Regualtions 2015, Please find enclosed copy of the news paper publications of unaudited standalone financial results for the Quarter and Nine .... (opens in a new tab)
Jan 2025
- 14 Jan · Routine
  Please find enclosed Newspaper publication of the EGM Notice scheduled to be held on February 6, 2025 (opens in a new tab)
- 10 Jan · Routine
  We are enclosing herewith certificate issued by Registrar and Share Transfer Agents of the Company .... (opens in a new tab)
Dec 2024
- 31 Dec · Routine
  Intimation of Closure of Trading Window under Regulation 30 of SEBI LODR 2015, for the Quarter ended 31.12.2024. (opens in a new tab)
Nov 2024
- 12 Nov · Routine
  Copies of the newspaper advertisements pertaining .... (opens in a new tab)
Oct 2024
- 9 Oct · Routine
  Compliances Certificate in terms of Regulation 74(5) of SEBI (DP) Regulations 2018, for the quarter ended September 30, 2024. (opens in a new tab)
Sep 2024
- 26 Sep · Routine
  Pursuant to SEBI (Prohibition of insider Trading), Regulations 2015, the Trading window will be closed for dealing in the securities of the company with effect from 1st October 2024 to .... (opens in a new tab)
Aug 2024
- 14 Aug · Routine
  Copies of the newspaper advertisement pertaining to Financial Results of the company for the .... (opens in a new tab)
Jul 2024
- 17 Jul · Routine
  Compliance Certificate issued by(RTA)CIL Securities Limited for the quarter ended 30.06.2024 under Regulation 74(5) of SEBI(DP) Regulations, 2018 (opens in a new tab)
May 2024
- 22 May · Routine
  Read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, submission of Annual Secretarial Compliance Report .... (opens in a new tab)
- 16 May · Routine
  Submission of Newspaper publication of Audited Financial Results for the Quarter and Year ended March 31, 2024 published under Regulation 47 of SEBI (LODR Regulations) , 2015 (opens in a new tab)
Mar 2024
- 27 Mar · Routine
  Intimation of closure of Trading Window, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 for the submission of Audited Financial Results for the quarter and Year ended .... (opens in a new tab)
Jan 2024
- 12 Jan · Routine
  Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 (opens in a new tab)
Dec 2023
- 28 Dec · Routine
  Intimation for Trading Window Closure from January 1, 2024 till 48 hours after the declaration of the Unaudited Standalone Financial Results for the Quarter and nine months period ended .... (opens in a new tab)
Nov 2023
- 13 Nov · Routine
  Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2023 (opens in a new tab)
Oct 2023
- 6 Oct · Routine
  Closure of Trading Window (opens in a new tab)
Dec 2020
- 30 Dec · Routine
  Closure of Trading Window for the Quarter ended 31.12.2020 (opens in a new tab)
Oct 2020
- 28 Oct · Routine
  Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the Quarter ended 30.09.2020 (opens in a new tab)
Sep 2020
- 30 Sep · Routine
  Closure of Trading Window for Quarter ended 30.09.2020 (opens in a new tab)
Jul 2020
- 15 Jul · Routine
  Certificate u/r 74(5) of SEBI (DP) Regulations,2018 (opens in a new tab)
Jun 2020
- 30 Jun · Routine
  Closure of trading window (opens in a new tab)
May 2020
- 30 May · Routine
  Certificate under Reg 74(5) of SEBI (DP) regulations, 2018 for the quarter ended 31.03.2020 (opens in a new tab)
Mar 2020
- 30 Mar · Routine
  Closure of Trading Window for the Quarter Ended 31.03.2020 (opens in a new tab)
Jan 2020
- 30 Jan · Routine
  Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 (opens in a new tab)

Venmax Drugs and Pharmaceuticals routine notices

Oct 2026

Sep 2026

Aug 2026

Jul 2026

Jun 2026

May 2026

Apr 2026

Mar 2026

Feb 2026

Jan 2026

Dec 2025

Nov 2025

Oct 2025

Sep 2025

Aug 2025

Jul 2025

Jun 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

May 2024

Mar 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023

Dec 2020

Oct 2020

Sep 2020

Jul 2020

Jun 2020

May 2020

Mar 2020

Jan 2020